Spatial navigation ability predicts progression of dementia symptomatology

Area of Science:

• Neuroscience
• Gerontology
• Cognitive Psychology

Background:

• Spatial navigation deficits are characteristic of Alzheimer's disease (AD).
• Longitudinal prediction of clinical decline using spatial navigation has been underexplored.
• Early identification of AD progression is crucial for timely intervention.

Purpose of the Study:

• To investigate the predictive ability of spatial navigation tasks for longitudinal clinical decline in Alzheimer's disease.
• To compare the predictive power of cognitive mapping (CM) and route learning (RL) with established biomarkers and episodic memory.
• To assess the diagnostic accuracy of spatial navigation measures in predicting clinical progression.

Main Methods:

• Assessed cognitive mapping (CM) in 95 participants and route learning (RL) in 65 participants at baseline.
• Tracked clinical progression over 4-5 years using the Clinical Dementia Rating (CDR) scale.
• Compared CM and RL predictive ability against episodic memory, hippocampus, and CSF biomarkers (ptau181/Aβ42 ratio).

Main Results:

• Both CM and RL predicted clinical progression (P < 0.032).
• CM and RL, along with episodic memory, demonstrated strong diagnostic accuracy (AUCs = 0.894, 0.794, 0.735, respectively).
• CM showed a trend towards better performance than episodic memory (P = 0.056) and interacted with biomarkers in prediction.

Conclusions:

• Baseline spatial navigation performance is a significant predictor of longitudinal clinical decline in Alzheimer's disease.
• Spatial navigation tasks offer valuable insights into AD progression, potentially serving as early risk assessment tools.
• Cognitive mapping, in particular, shows promise as a sensitive measure for predicting AD clinical trajectory.